10x Genomics (TXG) Asset Utilization Ratio (2019 - 2026)

10x Genomics (TXG) has 8 years of Asset Utilization Ratio data on file, last reported at 0.62 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 9.43% year-over-year to 0.62; the trailing twelve-month figure through Mar 2026 stood at 0.62 (down 9.43% YoY), and the FY2025 full-year result was 0.66, up 1.15% from the prior year.
• Asset Utilization Ratio steadied at 0.62 in Q1 2026, from 0.62 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.69 in Q1 2025 to a low of 0.49 in Q1 2022.
• A 5-year average of 0.6 and a median of 0.62 in 2025 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio surged 39.72% in 2022 and decreased 9.43% in 2026, its largest moves.
• Tracing TXG's Asset Utilization Ratio over 5 years: stood at 0.51 in 2022, then increased by 26.79% to 0.65 in 2023, then climbed by 1.76% to 0.66 in 2024, then declined by 5.56% to 0.62 in 2025, then retreated by 0.07% to 0.62 in 2026.
• Business Quant data shows TXG's Asset Utilization Ratio at 0.62 in Q1 2026, 0.62 in Q4 2025, and 0.64 in Q3 2025.